company background image
ZNO

Zoono GroupASX:ZNO Stock Report

Market Cap

AU$76.0m

7D

15.9%

1Y

-67.2%

Updated

18 Oct, 2021

Data

Company Financials
ZNO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

ZNO Overview

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Zoono Group
Historical stock prices
Current Share PriceAU$0.47
52 Week HighAU$0.38
52 Week LowAU$1.76
Beta-0.088
1 Month Change1.06%
3 Month Change-34.93%
1 Year Change-67.24%
3 Year Change375.00%
5 Year Changen/a
Change since IPO163.89%

Recent News & Updates

Sep 23
Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)

Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Sep 02
Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price Slump

Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price Slump

To the annoyance of some shareholders, Zoono Group Limited ( ASX:ZNO ) shares are down a considerable 27% in the last...

Aug 31
Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)

Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Zoono Group Limited...

Shareholder Returns

ZNOAU ChemicalsAU Market
7D15.9%0.08%0.9%
1Y-67.2%11.3%20.2%

Return vs Industry: ZNO underperformed the Australian Chemicals industry which returned 11.3% over the past year.

Return vs Market: ZNO underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is ZNO's price volatile compared to industry and market?
ZNO volatility
ZNO Beta-0.088
Industry Beta0.80
Market Beta1

Stable Share Price: ZNO is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: ZNO's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aPaul Hyslophttps://zoono.com

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. Its products include hand sanitizers, textile applicators, mold remediation, and surface sanitizers. The company serves airlines, manufacturing, healthcare, childcare, and other industries.

Zoono Group Fundamentals Summary

How do Zoono Group's earnings and revenue compare to its market cap?
ZNO fundamental statistics
Market CapNZ$79.77m
Earnings (TTM)NZ$4.73m
Revenue (TTM)NZ$27.13m

17.4x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ZNO income statement (TTM)
RevenueNZ$27.13m
Cost of RevenueNZ$11.03m
Gross ProfitNZ$16.10m
ExpensesNZ$11.37m
EarningsNZ$4.73m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.029
Gross Margin59.34%
Net Profit Margin17.44%
Debt/Equity Ratio0%

How did ZNO perform over the long term?

See historical performance and comparison

Dividends

6.4%

Current Dividend Yield

111%

Payout Ratio

Valuation

Is Zoono Group undervalued compared to its fair value and its price relative to the market?

7.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ZNO (A$0.48) is trading below our estimate of fair value (A$0.51)

Significantly Below Fair Value: ZNO is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: ZNO is good value based on its PE Ratio (17.4x) compared to the Australian Chemicals industry average (62x).

PE vs Market: ZNO is good value based on its PE Ratio (17.4x) compared to the Australian market (19.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ZNO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ZNO's PB Ratio (3.9x) is in line with the AU Chemicals industry average.


Future Growth

How is Zoono Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

31.0%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zoono Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Zoono Group performed over the past 5 years?

70.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ZNO has a high level of non-cash earnings.

Growing Profit Margin: ZNO's current net profit margins (17.4%) are lower than last year (43.5%).


Past Earnings Growth Analysis

Earnings Trend: ZNO has become profitable over the past 5 years, growing earnings by 70.4% per year.

Accelerating Growth: ZNO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ZNO had negative earnings growth (-71.6%) over the past year, making it difficult to compare to the Chemicals industry average (-61.8%).


Return on Equity

High ROE: ZNO's Return on Equity (22%) is considered high.


Financial Health

How is Zoono Group's financial position?


Financial Position Analysis

Short Term Liabilities: ZNO's short term assets (NZ$23.3M) exceed its short term liabilities (NZ$3.3M).

Long Term Liabilities: ZNO's short term assets (NZ$23.3M) exceed its long term liabilities (NZ$7.3M).


Debt to Equity History and Analysis

Debt Level: ZNO is debt free.

Reducing Debt: ZNO currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Debt Coverage: ZNO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ZNO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Zoono Group current dividend yield, its reliability and sustainability?

6.44%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ZNO's dividend (6.44%) is higher than the bottom 25% of dividend payers in the Australian market (2.27%).

High Dividend: ZNO's dividend (6.44%) is in the top 25% of dividend payers in the Australian market (5.32%)


Stability and Growth of Payments

Stable Dividend: Too early to tell whether ZNO's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if ZNO's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (110.7%), ZNO's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

Paul Hyslop

no data

Tenure

NZ$480,000

Compensation

Mr. Paul Hyslop has been the Managing Director and Director of Zoono Group Limited since April 26, 2017 and serves as its Chief Executive Officer. Mr. Hyslop's primary responsibility is to determine the st...


CEO Compensation Analysis

Compensation vs Market: Paul's total compensation ($USD339.61K) is about average for companies of similar size in the Australian market ($USD302.72K).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ZNO's management team is considered experienced (4.4 years average tenure).


Board Members

Experienced Board: ZNO's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Zoono Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Zoono Group Limited
  • Ticker: ZNO
  • Exchange: ASX
  • Founded: 1986
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: AU$76.044m
  • Shares outstanding: 165.31m
  • Website: https://zoono.com

Location

  • Zoono Group Limited
  • 24 Bishop Dunn Place
  • Botany South
  • Auckland
  • 2013
  • New Zealand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 07:05
End of Day Share Price2021/10/18 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.